Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease
Authors:
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (1) , 20-23
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery DiseaseCirculation, 2003
- Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary StentingCirculation, 2002
- Platelet glycoprotein IIb/IIIa antagonists: Lessons learned from clinical trials and future directionsCritical Care Medicine, 2002
- Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) StudyCirculation, 2002
- Short- and Long-Term Black Tea Consumption Reverses Endothelial Dysfunction in Patients With Coronary Artery DiseaseCirculation, 2001
- Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.Heart, 1995
- Correlation of cold pressor and flow-mediated brachial artery diameter responses with the presence of coronary artery diseaseThe American Journal of Cardiology, 1995